Back to top
more

NewLink Genetics Corporation (NLNK)

(Delayed Data from NSDQ)

$1.79 USD

1.79
854,824

+0.06 (3.47%)

Updated May 3, 2019 04:00 PM ET

After-Market: $1.78 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

NewLink (NLNK) to Report Q4 Earnings: What's in the Cards?

by Zacks Equity Research

Investors are looking forward to updates on NewLink's (NLNK) merger with Lumos Pharma, when the former releases fourth-quarter 2019 results.

Company News For Dec 26, 2019

by Zacks Equity Research

Companies In The News Are: SSNT, NLNK, CVM, AXE

Do Options Traders Know Something About NewLink Genetics (NLNK) Stock We Don't?

by Zacks Equity Research

Investors need to pay close attention to NewLink Genetics (NLNK) stock based on the movements in the options market lately.

Company News For Sep 19, 2019

by Zacks Equity Research

Companies in the news are: FDX, BYND, SPI, NLNK

Is the Options Market Predicting a Spike in NewLink Genetics (NLNK) Stock?

by Zacks Equity Research

Investors need to pay close attention to NewLink Genetics (NLNK) stock based on the movements in the options market lately.

Implied Volatility Surging for NewLink Genetics (NLNK) Stock Options

by Zacks Equity Research

Investors need to pay close attention to NewLink Genetics (NLNK) stock based on the movements in the options market lately.

Celgene (CELG) Hits 52-Week High, Can the Run Continue?

by Zacks Equity Research

Celgene (CELG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

The Zacks Analyst Blog Highlights: ANI, Kamada, Genomic Health and NewLink

by Zacks Equity Research

The Zacks Analyst Blog Highlights: ANI, Kamada, Genomic Health and NewLink

4 Small Biotech Stocks Likely to Witness More Upside in 2019

by Zacks Equity Research

The biotech space is witnessing a rally so far in 2019. Here we discuss four stocks that are likely to witness a continuation of the uptrend going ahead.

Is the Options Market Predicting a Spike in NewLink Genetics (NLNK) Stock? (revised)

by Zacks Equity Research

Investors need to pay close attention to NewLink Genetics (NLNK) stock based on the movements in the options market lately.

Is the Options Market Predicting a Spike in Hertz NewLink Genetics (NLNK) Stock?

by Zacks Equity Research

Investors need to pay close attention to Hertz NewLink Genetics (NLNK) stock based on the movements in the options market lately.

NewLink Genetics (NLNK) Reports Q3 Loss, Lags Revenue Estimates

by Zacks Equity Research

NewLink (NLNK) delivered earnings and revenue surprises of 52.38% and -94.29%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

NewLink Genetics (NLNK) Q3 Earnings Preview: What to Expect

by Zacks Equity Research

NewLink (NLNK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NewLink Shares Plunge After Incyte & Merck's Study Fails

by Zacks Equity Research

Shares of NewLink Genetics Corp. (NLNT) plunged about 42.6% following the news of the failure of Incyte and Merck's phase III combination study for metastatic melanoma.

    Incyte's Epacadostat Fails in Melanoma Study, Shares Plunge

    by Zacks Equity Research

    Incyte's (INCY) epacadostat in combination with Merck's Keytruda fails to meet primary endpoint of PFS in a phase III melanoma study.

      Options Traders Expect Huge Moves in NewLink Genetics (NLNK) Stock

      by Zacks Equity Research

      Surging implied volatility makes NewLink Genetics (NLNK) stock lucrative to the option traders.

        NewLink Genetics (NLNK) Jumps: Stock Rises 29.9%

        by Zacks Equity Research

        NewLink Genetics (NLNK) shares rose nearly 30% in the last trading session, amid huge volumes.

          Options Traders Expect Huge Moves in NewLink Genetics (NLNK) Stock

          by Zacks Equity Research

          High level of implied volatility makes NewLink Genetics (NLNK) Stock lucrative to the option traders.

            Are Options Traders Betting on a Big Move in NewLink (NLNK) Stock?

            by Zacks Equity Research

            NewLink (NLNK) needs Investors to pay close attention to the stock based on moves in the options market lately.

              NewLink Genetics (NLNK): Moving Average Crossover Alert

              by Zacks Equity Research

              NewLink Genetics Corporation (NLNK) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front

                Will NewLink Genetics (NLNK) Continue to Surge Higher?

                by Zacks Equity Research

                As of late, it has definitely been a great time to be an investor in NewLink Genetics Corp (NLNK).

                  NewLink Genetics (NLNK) Jumps: Stock Adds 10% in Session

                  by Zacks Equity Research

                  NewLink Genetics Corporation (NLNK) shares rose almost 10% in the last trading session.